Summary
For Year 2026-27, Jubilant Pharmova reports the following shareholding: Total Promoters at 47.68%, Mutual Fund at 8.03%, Insurance at 1.13%, Foreign Institutional Investors at 15.9%, Domestic Institutional Investors at 2.46%, and Retail at 24.8%. This breakdown provides a quick snapshot of ownership distribution for Jubilant Pharmova in 2026-27.
Jubilant Pharmova FAQs
As of 05-2026, the promoter shareholding in Jubilant Pharmova stands at 47.68% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.
The FII and DII shareholding of Jubilant Pharmova is 15.9% and 2.46% respectively.
The retail shareholding of the Jubilant Pharmova is 24.8%.
Changes in shareholding patterns of Jubilant Pharmova can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.
Shareholding patterns of Jubilant Pharmova are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.
The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.
Jubilant Pharmova Associated Pages
